All In MedTech

FDA Clearance Tracker · P190028-S023

cobas HPV

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 16, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P190028-S023
Device name
cobas HPV
Applicant location
Pleasanton, CA
Received
Jan 5, 2026
Decided
Jun 16, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P190028

Device type

Device class
Class III

Every decision under product code MAQ

FDA's approval statement

As written in FDA's record.

Approval for cobas HPV on the upgraded cobas 6800/8800 systems 2.0

Source documents

Other decisions for Roche Molecular Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.